Bruce Culleton - 01 Aug 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
EVP, Clinical Development
Signature
/s/ Todd Girolamo, attorney in fact
Issuer symbol
PROK
Transactions as of
01 Aug 2023
Net transactions value
$0
Form type
4
Filing time
03 Aug 2023, 08:52:29 UTC
Previous filing
25 Jul 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +485,000 $0.000000 485,000 01 Aug 2023 Class A Ordinary Shares 485,000 $13.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on 1st anniversary of August 1, 2023 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter.